The NordicPharmaTrain is consolidating world-leading research and education in the Nordics within drug delivery, contemporary pharmaceutical manufacturing and clinical implementation with focus on translation and innovation in pharmaceutical research.
The Nordic countries lie at the boundary between two structurally different biomes: boreal forests, dominated by trees, and the tundra, dominated by low-lying vegetation. This biome boundary is currently shifting because of ongoing climate warming and changes in land use.
Mental disorders are complex traits arising from both inherited and environmental contributions, particularly during early life phases. Understanding how interplay between nature and nurture during these sensitive early phases creates individual differences in human mental traits is a fundamental question spanning the social and life sciences.
Molecular medicine is the science of how humans function at the most basic level of genes, proteins and cells. It aims to understand and manipulate molecular processes to diagnose and cure diseases. Molecular medicine improves diagnosis, discovers effective individualized treatments for cancer and immune disorders, and creates vaccines against lethal infections.
The Nordic Added Value 2030 project explores the conceptualization of the principle of Nordic added value across the work of the Nordic Council and the Nordic Council of Ministers, and the latter’s subsidiary institutions.
Multi-method research project that will compare mental wellbeing trends within, and between, four Nordic countries (Finland, Iceland, Norway and Sweden) before, during and after the COVID-19 pandemic.
Project aiming to improve our understanding of the welfare for children and young people and the consequences of the pandemic and the restrictions on education, wellbeing, mental health, and living conditions.
